关于新生儿血小板减少症的研究
A Study on Thrombocytopenia in Neonates
DOI: 10.12677/ACM.2022.122178, PDF,   
作者: 李梦妍*, 吴亚臻#:青海大学附属医院儿科,青海 西宁
关键词: 新生儿血小板减少症出血Neonates Thrombocytopenia Bleeding
摘要: 通过对国内外新生儿血小板减少症的定义、流行病学、原因等方面进行分析,评价引起新生儿血小板减少症发生出血的危险因素,并讨论当前有效治疗方案,以期为新生儿血小板减少症诊疗提供依据。
Abstract: By analyzing the definition, epidemiology and causes of neonatal thrombocytopenia at home and abroad, the risk factors of neonatal thrombocytopenia hemorrhage were evaluated, and the current effective treatment plan was discussed, in order to provide a basis for the diagnosis and treatment of neonatal thrombocytopenia.
文章引用:李梦妍, 吴亚臻. 关于新生儿血小板减少症的研究[J]. 临床医学进展, 2022, 12(2): 1229-1234. https://doi.org/10.12677/ACM.2022.122178

参考文献

[1] Brunner, B., Hoeck, M., Schermer, E., et al. (2013) Patent Ductus Arteriosus, Low Platelets, Cyclooxygenase Inhibitors, and intraventricular Hemorrhage in Very Low Birth Weight Preterm Infants. The Journal of Pediatrics, 163, 23-28. [Google Scholar] [CrossRef] [PubMed]
[2] Karakurtn, N., Uslu, I., Albayrak, C., et al. (2018) Neonates Born to Mothers with Immune Thrombocytopenia: 11 Years Experience of a Single Academic Center. Blood Coagulation & Fibrinolysis, 29, 546-550. [Google Scholar] [CrossRef
[3] Venkatesh, V., Curley, A., Khan, R., et al. (2013) A Novel Approach to Standardised Recording of Bleeding in a High Risk Neonatal Population. ADC Fetal & Neonatal Edition, 98, F260-F263. [Google Scholar] [CrossRef] [PubMed]
[4] Boutaybi, N., Steggerda, S.J., Smits-Wintjens, V.E.H.J., et al. (2013) Early-Onset Thrombocytopenia in Near-Term and Term Infants with Perinatal Asphyxia. Vox Sanguinis, 106, 361-367. [Google Scholar] [CrossRef] [PubMed]
[5] Bussel, J.B., de Miguel, P.G., Despotovic, J.M., et al. (2015) Eltrombopag for the Treatment of Children with Persistent and Chronic Immune Thrombocytopenia (PETIT): A Randomised, Multicentre, Placebo-Controlled Study. The Lancet Haematology, 2, E315-E325. [Google Scholar] [CrossRef
[6] 肖秀漫, 江程程, 姜娜, 等. 新生儿血小板减少症259例临床分析[J]. 医学研究杂志, 2016, 45(11): 124-128.
[7] Delbos, F., Bertrand, G., Croisille, L., Ansart-Pirenne, H., Bierling, P. and Kaplan, C. (2016) Fetal and Neonatal Alloimmune Thrombocytopenia: Predictive Factors of Intracranial Hemorrhage. Transfusion, 56, 59-66. [Google Scholar] [CrossRef] [PubMed]
[8] Zdravic, D., Yougbare, I., Vadaszb, B., et al. (2016) Fetal and Neonatal Alloimmune Thrombocytopenia. Seminars in Fetal & Neonatal Medicine, 21, 19-27. [Google Scholar] [CrossRef] [PubMed]
[9] 蒋亚君, 陈师, 王雪秋, 等. 足月小样儿早发型血小板减少症围生期危险因素配对对照研究[J]. 临床儿科杂志, 2018, 36(1): 40-43+60.
[10] Bayhan, T., Tavil, B., Korkmaz, A., et al. (2016) Neonates Born to Mothers with Immune Thrombocytopenic Purpura: A Single-Center Experience of 20 Years. Blood Coagulation & Fibrinolysis, 27, 19-23. [Google Scholar] [CrossRef
[11] Koyama, S., Tomimatsu, T., Kanagawa, T., et al. (2012) Reliable Predictors of Neonatal Immune Thrombocytopenia in Pregnant Women with Idiopathic Thrombocytopenic Purpura. American Journal of Hematology, 87, 15-21. [Google Scholar] [CrossRef] [PubMed]
[12] Manukjan, G., Bosing, H., Schmugge, M., et al. (2017) Impact of Genetic Variants on Haematopoiesis in Patients with Thrombocytopenia Absent Radii (TAR) Syndrome. British Journal of Haematology, 179, 606-617. [Google Scholar] [CrossRef] [PubMed]
[13] Kumarm, K., Chaudhary, I.P., Ranjan, R.B., et al. (2015) Thrombocytopenia with Unilateral Dysplastic Radius—Is It Thrombocytopenia-Absent Radius (TAR) Syndrome? Journal of Clinical and Diagnostic Research, 9, SD01-SD02. [Google Scholar] [CrossRef
[14] Alter, B.P. (2014) Fanconi Anemia and the Development of Leukemia. Best Practice & Research Clinical Haematology, 27, 214-221. [Google Scholar] [CrossRef] [PubMed]
[15] Newman, L.A., Luter, M.A., Davis, D.B., et al. (2017) Congenital Amegakaryocytic Thrombocytopenia: A Case Series Indicating 2 Founder Variants in the Mississippi Band of Choctaw Indians. Journal of Pediatric Hematology/Oncology, 39, 573-575. [Google Scholar] [CrossRef
[16] Zhang, Y.N. and Zhang, Q. (2017) Research Progress in Congenital Amegakaryocytic Thrombocytopenia. Chinese Journal of Pediatrics, 55, 155-158.
[17] Liu, N., Shi, H., Kong, X., et al. (2014) Mutation Analysis of WASP Gene and Prenatal Diagnosis of Wiskott-Aldrich Syndrome. Chinese Journal of Pediatrics, 52, 662-666.
[18] Rajagopal, R., Thachil, J. and Monagle, P. (2017) Disseminated Intravascular Coagulation in Paediatrics. Archives of Disease in Childhood, 102, 187-193. [Google Scholar] [CrossRef] [PubMed]
[19] Saxonhouse, M.A. (2015) Thrombosis in the Neonatal Intensive Care Unit. Clinics in Perinatology, 42, 651-673. [Google Scholar] [CrossRef] [PubMed]
[20] Kjeldsen-Kragh, J., Titze, T.L., Lie, B.A., Vaage, J.T. and Kjær, M. (2019) HLA-DRB3*01:01 Exhibits a Dose-Dependent Impact on HPA-1a Antibody Levels in HPA-1a-Immunized Women. Blood Advances, 3, 945-951. [Google Scholar] [CrossRef] [PubMed]
[21] Tarantino, M.D., Bussel, J.B., Blanchette, V.S., et al. (2016) Romiplostim in Children with Immune Thrombocytopenia: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study. The Lancet, 388, 45-54. [Google Scholar] [CrossRef
[22] Lieberman, L., Greinacher, A., Murphy, M.F., et al. (2019) International Collaboration for Transfusion Medicine Guidelines (ICTMG). Fetal and Neonatal Alloimmune Thrombocytopenia: Recommendations for Evidence-Based Practice, an International Approach. British Journal of Haematology, 185, 549-562. [Google Scholar] [CrossRef] [PubMed]
[23] Bussel, J.B., Arnold, D.M., Boxer, M.A., et al. (2019) Long-Term Fostamatinib Treatment of Adults with Immune Thrombocytopenia during the Phase 3 Clinical Trial Program. American Journal of Hematology, 94, 546-553. [Google Scholar] [CrossRef] [PubMed]
[24] Akman, A.O., Kara, F.K., Koksal, T., Cakir, B.C., Karagol, C. and Sayli, T. (2017) Association of Hemolysis with High Dose Intravenous Immunoglobulin Therapy in Pediatric Patients: An Open-Label Prospective Trial. Transfusion and Apheresis Science, 56, 531-534. [Google Scholar] [CrossRef] [PubMed]
[25] Baker, J., Shehata, N., Murphy, M.F., Greinacher, A., Bakchoul, T., Massey, E., Lieberman, L., Landry, D., Tanael, S., Arnold, D.M., Baidya, S., Bertrand, G., Bussel, J., Kjaer, M., Kaplan, C., Kjeldsen-Kragh, J., Oepkes, D., Savoia, H., Ryan, G. and Hume, H. (2018) Postnatal Intervention for the Treatment of Fetal and Neonatal Alloimmune Thrombocytopenia: A Systematic Review. Vox Sanguinis, 113, 113-118.
[26] Newland, A., Godeau, B., Priego, V., et al. (2016) Remission and Platelet Responses with Romiplostim in Primary Immune Thrombocytopenia: Final Results from a Phase 2 Study. British Journal of Haematology, 172, 262-273. [Google Scholar] [CrossRef] [PubMed]
[27] Ahmed, R., Devasia, A.J., Viswabandya, A., et al. (2016) Long-Term Outcome Following Splenectomy for Chronic and Persistent Immune Thrombocytopenia (ITP) in Adults and Children: Splenectomy in ITP. Annals of Hematology, 95, 1429-1434. [Google Scholar] [CrossRef] [PubMed]
[28] Leadford, A.E., Warren, J.B., Manasyan, A., Chomba, E., Salas, A.A., Schelonka, R., et al. (2013) Plastic Bags for Prevention of Hypothermia in Preterm and Low Birthweight Infants. Pediatrics, 132, e128-134. [Google Scholar] [CrossRef] [PubMed]
[29] Boulton, F. (2004) Transfusion Guidelines for Neonates and Older Children. British Journal of Haematology, 124, 433-453. [Google Scholar] [CrossRef] [PubMed]
[30] Zheng, D., Huang, C.S., Huang, S.B. and Zheng, C.X. (2016) Laparoscopic Splenectomy for Primary Immune Thrombocytopenia: Current Status and Challenges. World Journal of Gastrointestinal Endoscopy, 8, 610-615. [Google Scholar] [CrossRef] [PubMed]
[31] Tiller, H., Husebekk, A., Ahlen, M.T., et al. (2017) Current Perspectives on Fetal and Neonatal Alloimmune Thrombocytopenia—Increasing Clinical Concerns and New Treatment Opportunities. International Journal of Women’s Health, 9, 223-234. [Google Scholar] [CrossRef
[32] Regan, F., Lees, C.C., Jones, B., et al. (2019) Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No.61. BJOG: An International Journal of Obstetrics & Gynaecology, 126, e173-e185. [Google Scholar] [CrossRef] [PubMed]
[33] Petermann, R., Bakchoul, T., Curtis, B.R., et al. (2018) Investigations for Fetal and Neonatal Alloimmune Thrombocytopenia: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 16, 2526- 2529. [Google Scholar] [CrossRef] [PubMed]
[34] Benjamin, R.J., Dy, B., Perez, J., et al. (2014) Bacterial Culture of Apheresis Platelets: A Mathematical Model of the Residual Rate of Contamination Based on Unconfirmed Positive Results. Vox Sanguinis, 106, 23-30. [Google Scholar] [CrossRef] [PubMed]
[35] 郝欣欣, 邓晶, 丛桂敏, 等. 胎儿/新生儿同种免疫性血小板减少症的诊断——附1例并文献复习[J]. 中国输血杂志, 2020, 33(11): 1167-1172.
[36] Estcourt, L.J., Birchall, J., Allard, S., et al. (2017) Guidelines for the Use of Platelet Transfusions. British Journal of Haematology, 176, 365-394. [Google Scholar] [CrossRef] [PubMed]
[37] Hutchinson, A.L., Dennington, P.M., Holdsworth, R., et al. (2015) Recurrent HLA-B56 Mediated Neonatal Alloimmune Thrombocytopenia with Fatal Outcomes. Transfusion and Apheresis Science, 52, 311-313. [Google Scholar] [CrossRef] [PubMed]
[38] Sachs, U.J., Wienzek-Lischka, S., Duong, Y., et al. (2020) Maternal Anti-Bodies against Paternal Class I Human Leukocyte Antigens Are Not Associated with Foetal and Neonatal Alloimmune Thrombocytopenia. British Journal of Haematology, 189, 751-759. [Google Scholar] [CrossRef] [PubMed]
[39] Curtis, B.R. (2015) Recent Progress in Understanding the Pathogenesis of Fetal and Neonatal Alloimmune Thrombocytopenia. British Journal of Haematology, 171, 671-682. [Google Scholar] [CrossRef] [PubMed]
[40] 马德冉, 赵莉, 田野, 等. 6例新生儿同种免疫性血小板减少症临床资料回顾分析[J]. 中国输血杂志, 2020, 33(10): 1026-1028.